This two day interactive conference will provide 200 key decision makers strategic and scientific knowledge in Biosimilarsand Follow-On Biologics. Leaders with scientific, business, and regulatory interests will discuss and address challenges in the development, production and launch of these complex medicines.
The primary aim is to identify key issues that will arise, and begin to solve these issues in situ.
It is an unrivalled marketing solution that will provide you with knowledge on the future of the industry, new contacts, and great exposure. The event is designed to ensure the long term health of the ecosystem, and therefore unites end users, key clients, and crucial players.
Dig deep into the scientific foundations at the core of biosimilar development
Understand how to translate regulatory expectations into trial concepts with global best practice strategies in clinical trial design and execution
Master biosimilar manufacture, process development and scale up
Find out where the true biosimilar industry growth opportunities lie and what role they can play in your portfolio
Identify innovative tools and techniques for immunogenicity
Understand how to operate in the regulatory environment in Europe, Asia and America with input from key regulatory bodies
Gain an investor’s perspective and understand what this means for your business
Review recent partnering and M&A activities and the resulting impact on the biosimilar industry
Transform good science into a better approval process and increase patient access
Double your opportunities - choose to attend Biosimilars Drug Development World or the parallel World Generic Medicines Congress to learn and network with colleagues across both events